LGVN insider transaction filings
Longeveron Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-25. Screen LGVN transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 18 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 19.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
+4 more insiders in the window, not shown — every filing appears in the table below.
Recent Form 4 filings — Longeveron Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-25 | 4 | Jhaveri Nirav S. — Chief Financial Officer | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2026-08-21 | 4 | Hare Joshua — Chief Scientific Officer, Director, 10% owner | Grant/award (A): 286,000 @ $0 | EDGAR |
| 2026-08-21 | 4 | Ascheim Deborah — Director | Grant/award (A): 36,000 @ $0 | EDGAR |
| 2026-08-21 | 4 | Agafonova Nataliya — Chief Medical Officer | Grant/award (A): 286,000 @ $0 | EDGAR |
| 2026-08-21 | 4 | Blass Devin — CTO & SVP of CMC | Grant/award (A): 286,000 @ $0 | EDGAR |
| 2026-08-21 | 4 | Desai Arjun JJ — Director | Grant/award (A): 36,000 @ $0 | EDGAR |
| 2026-08-21 | 4 | Cann Leah Rush — Director | Grant/award (A): 36,000 @ $0 | EDGAR |
| 2026-08-21 | 4 | Ungaro Ursula — Director | Grant/award (A): 36,000 @ $0 | EDGAR |
| 2026-08-21 | 4 | Paletta George A. Jr. — Director | Grant/award (A): 36,000 @ $0 | EDGAR |
| 2026-08-21 | 4 | Soffer Rock — Director | Grant/award (A): 36,000 @ $0 | EDGAR |
| 2026-08-21 | 4 | Hajjar Roger Joseph — Director | Grant/award (A): 36,000 @ $0 | EDGAR |
| 2026-08-21 | 4 | Lehr Paul T — General Counsel, Secretary | Grant/award (A): 286,000 @ $0 | EDGAR |
| 2026-07-08 | 4 | Hare Joshua — Chief Scientific Officer, Director, 10% owner | Grant/award (A): 600,000 @ $0 · Grant/award (A): 400,000 (derivative) @ $0 | EDGAR |
| 2026-07-06 | 4 | Locklear Lisa — Chief Financial Officer | Tax withholding (F): 22,505 @ $0.73 | EDGAR |
| 2026-07-06 | 4 | Agafonova Nataliya — Chief Medical Officer | Tax withholding (F): 22,505 @ $0.73 | EDGAR |
| 2026-07-06 | 4 | Blass Devin — CTO & SVP of CMC | Tax withholding (F): 15,808 @ $0.73 | EDGAR |
| 2026-07-06 | 4 | Lehr Paul T — General Counsel, Secretary | Tax withholding (F): 13,143 @ $0.73 | EDGAR |
| 2026-07-06 | 4 | Willard Stephen H — Chief Executive Officer | Tax withholding (F): 18,046 @ $0.73 | EDGAR |
| 2026-05-05 | 4 | Lehr Paul T — General Counsel, Secretary | Grant/award (A): 250,000 @ $0 | EDGAR |
| 2026-05-05 | 4 | Blass Devin — CTO & SVP of CMC | Grant/award (A): 250,000 @ $0 | EDGAR |
| 2026-05-05 | 4 | Agafonova Nataliya — Chief Medical Officer | Grant/award (A): 250,000 @ $0 | EDGAR |
| 2026-05-05 | 4 | Locklear Lisa — Chief Financial Officer | Grant/award (A): 250,000 @ $0 | EDGAR |
| 2026-05-05 | 4 | Willard Stephen H — Chief Executive Officer | Grant/award (A): 500,000 @ $0 | EDGAR |
| 2026-04-03 | 4 | Lehr Paul T — General Counsel, Secretary | Tax withholding (F): 5,611 @ $1.12 | EDGAR |
| 2026-04-03 | 4 | Agafonova Nataliya — Chief Medical Officer | Tax withholding (F): 13,145 @ $1.12 | EDGAR |
| 2026-04-03 | 4 | Locklear Lisa — Chief Financial Officer | Tax withholding (F): 13,145 @ $1.12 | EDGAR |
| 2026-04-03 | 4 | Blass Devin — CTO & SVP of CMC | Tax withholding (F): 8,633 @ $1.12 | EDGAR |
| 2026-04-03 | 4 | Willard Stephen H — Chief Executive Officer | Tax withholding (F): 4,740 @ $1.12 | EDGAR |
| 2026-03-13 | 4 | Willard Stephen H — Chief Executive Officer | Grant/award (A): 200,000 @ $0 · Tax withholding (F): 105,533 @ $0.55 · Grant/award (A): 200,000 @ $0 · Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Agafonova Nataliya — Chief Medical Officer | Tax withholding (F): 10,250 @ $0.59 | EDGAR |
| 2026-01-06 | 4 | Lehr Paul T — General Counsel, Secretary | Tax withholding (F): 6,952 @ $0.59 | EDGAR |
| 2026-01-06 | 4 | Locklear Lisa — Chief Financial Officer | Tax withholding (F): 10,250 @ $0.59 | EDGAR |
| 2026-01-06 | 4 | Blass Devin — CTO & SVP of CMC | Tax withholding (F): 10,700 @ $0.59 | EDGAR |
| 2026-01-06 | 4 | Powell James Nathaniel — Chief Executive Officer | Tax withholding (F): 2,464 @ $0.59 | EDGAR |
| 2025-10-27 | 4 | Paletta George A. Jr. — Director | Grant/award (A): 34,000 @ $0 | EDGAR |
| 2025-10-03 | 4 | Agafonova Nataliya — Chief Medical Officer | Tax withholding (F): 11,883 @ $0.74 | EDGAR |
| 2025-10-03 | 4 | Powell James Nathaniel — Chief Executive Officer | Tax withholding (F): 2,389 @ $0.74 | EDGAR |
| 2025-10-03 | 4 | Lehr Paul T — General Counsel, Secretary | Tax withholding (F): 4,944 @ $0.74 | EDGAR |
| 2025-10-03 | 4 | Blass Devin — CTO & SVP of CMC | Tax withholding (F): 7,609 @ $0.74 | EDGAR |
| 2025-10-03 | 4 | Locklear Lisa — Chief Financial Officer | Tax withholding (F): 11,883 @ $0.74 | EDGAR |
| 2025-10-01 | 4 | Powell James Nathaniel — Chief Executive Officer | Grant/award (A): 50,000 @ $0 · Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2025-08-13 | 4 | Locklear Lisa — Chief Financial Officer | Purchase (P): 11,766 · Purchase (P): 29,415 (derivative) | EDGAR |
| 2025-08-13 | 4 | Baluch Khoso — Director | Purchase (P): 11,766 · Purchase (P): 29,415 (derivative) | EDGAR |
| 2025-07-17 | 4 | Blass Devin — CTO & SVP of CMC | Grant/award (A): 102,000 @ $0 · Grant/award (A): 34,000 (derivative) @ $0 | EDGAR |
| 2025-07-17 | 4 | Hashad Mohamed Wa'el Ahmed — Chief Executive Officer | Grant/award (A): 180,000 @ $0 · Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2025-07-17 | 4 | Motwani Neha J. — Director | Grant/award (A): 17,000 @ $0 | EDGAR |
| 2025-07-17 | 4 | Ungaro Ursula — Director | Grant/award (A): 17,000 @ $0 | EDGAR |
| 2025-07-17 | 4 | Baluch Khoso — Director | Grant/award (A): 17,000 @ $0 | EDGAR |
| 2025-07-17 | 4 | Hare Joshua — Chief Scientific Officer, Director, 10% owner | Grant/award (A): 109,000 (derivative) @ $0 | EDGAR |
| 2025-07-17 | 4 | Kender Richard N — Director | Grant/award (A): 17,000 @ $0 | EDGAR |
Recent 8-K events — Longeveron Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-14 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-08-24 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-19 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-29 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-07-14 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-08 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-07-06 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-05 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-05-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=LGVN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →